PHARMA – September 2018

PHARMA - September 2018

Provider: OA National Provider

Contact: Optometry Australia OA Provider, [E] s.hanna@optometry.org.au, [P] 96688550

Learning Objectives

• ...be updated on and become more familiar with new clinical guidelines for diabetic retinopathy
• .....become more familiar with the early retinal changes of children diagnosed with diabetes
• ...understand the pharmacology of systemic/oral therapeutic medications and their beneficial and non-beneficial/side effects
• ...become more familiar with the therapeutic medication management of ocular allergy and how oral routes of administration may impact on the prescribing of topical therapeutic agents
• ...become more familiar with the therapeutic medication management of ocular pain and inflammation and how oral routes of administration may impact on the prescribing of topical therapeutic agents
• ...become more familiar with the therapeutic medication management of ocular bacterial and viral infections and how oral routes of administration may impact on the prescribing of topical therapeutic agents
• ...become more familiar with the therapeutic medication management of markedly elevated IOP and how oral routes of administration may supplement the prescribing of topical therapeutic agents
• ...understand the benefits of ultra-widefield imaging in the detection and more accurate assessment of retinopathy and other retinal lesions
• ...become more familiar with the emerging role of artificial intelligence in relation to diagnosis, treatment regimens and patient outcomes in the setting of ocular disease
• ...become more familiar with the various signs of retinal vascular disease
• ...become more familiar with the use of Fenofibrate and Eplerenone and its impact on the therapeutic medication management of patients with T2DM and mild to moderate NPDR and CSCR respectively

Max points awarded: 6.00

Session Information